ALNOV Novacyt S.A.
0.4610EUR+2.44%Mkt Cap: 36.33M $P/E: —Today
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmenta…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap36.33M USD
Enterprise Value36.86M USD
Revenue (TTM)23.69M USD
Gross Profit13.71M USD
Net Income (TTM)-24.87M USD
Revenue/Share0.30 EUR
Last Price0.4610 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees216
CountryFR
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)1.73
PEG—
EV/EBITDA9.10
EV/Revenue1.56
P/S1.50
P/B1.48
EPS (TTM)-0.36
EPS (Forward)0.26
52W Range
0.290023% of range1.040
52W High1.040 EUR
52W Low0.2900 EUR
Profitability
Gross Margin62.98%
Oper. Margin-44.17%
EBITDA Margin17.09%
Profit Margin-114.25%
ROE-97.91%
ROA-56.74%
Growth
Revenue Growth18.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.79M USD
CapEx (TTM)957.61K USD
FCF Margin29.12%
FCF Yield18.99%
Net Debt1.44M USD
Net Debt/EBITDA0.35
Balance Sheet
Debt/Equity0.45
Current Ratio3.14
Quick Ratio2.19
Book Value/Sh0.30 EUR
Cash/Share0.12 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.72.50M
Float72.21M
Insiders0.06%
Institutions0.00%
Technical
SMA 500.4891 (-5.7%)
SMA 2000.4406 (+4.6%)
Beta—
S&P 52W Chg14.58%
Avg Vol (30d)245.93K
Avg Vol (10d)275.04K
Technical Indicators
RSI (14)39.8
MACD-0.0055
MACD Signal-0.0003
MACD Hist.-0.0052
BB Upper0.5276 EUR
BB Middle0.4930 EUR
BB Lower0.4585 EUR
BB Width14.00%
ATR (14)0.0249 EUR
Vol Ratio (20d)1.02x